CY1117560T1 - Νεο υποκατασταθεν παραγωγο ισοκινολινης - Google Patents
Νεο υποκατασταθεν παραγωγο ισοκινολινηςInfo
- Publication number
- CY1117560T1 CY1117560T1 CY20161100465T CY161100465T CY1117560T1 CY 1117560 T1 CY1117560 T1 CY 1117560T1 CY 20161100465 T CY20161100465 T CY 20161100465T CY 161100465 T CY161100465 T CY 161100465T CY 1117560 T1 CY1117560 T1 CY 1117560T1
- Authority
- CY
- Cyprus
- Prior art keywords
- optionally substituted
- group
- hydrogen atom
- isokinolin
- production
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Abstract
Παρέχεται ένα νέο παράγωγο ισοκινολιν-6-σουλφοναμίδιου το οποίο είναι χρήσιμο ως φάρμακο. Ένα παράγωγο ισοκινολιν-6-σουλφοναμιδίου αναπαρίσταται από το γενικό τύπο (1) (στον τύπο, τα R1 και R2 αντιπροσωπεύουν ανεξάρτητα ένα άτομο υδρογόνου ή τα όμοια· τα R3 και R4 αντιπροσωπεύουν ανεξάρτητα ένα άτομο υδρογόνου, μία ομάδα αλκυλίου ή τα όμοια· το R5 αντιπροσωπεύει ένα άτομο υδρογόνου, μία προαιρετικά υποκατασταθείσα ομάδα αλκυλίου, μία προαιρετικά υποκατασταθείσα ομάδα αλκενυλίου, μία προαιρετικά υποκατασταθείσα ομάδα αλκυνυλίου, μία προαιρετικά υποκατασταθείσα ομάδα κυκλοαλκυλίου, μία προαιρετικά υποκατασταθείσα ομάδα αλκανοϋλίου ή τα όμοια· το Α αντιπροσωπεύει μία ευθύγραμμη ή διακλαδούμενη ομάδα αλκυλενίου με C2-6), ένα άλας αυτού ή ένα στερεό διάλυμα αυτών.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010286445 | 2010-12-22 | ||
| EP11851146.8A EP2657227B1 (en) | 2010-12-22 | 2011-12-21 | Novel substituted isoquinoline derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1117560T1 true CY1117560T1 (el) | 2017-04-26 |
Family
ID=46313995
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20161100465T CY1117560T1 (el) | 2010-12-22 | 2016-05-27 | Νεο υποκατασταθεν παραγωγο ισοκινολινης |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US8883792B2 (el) |
| EP (1) | EP2657227B1 (el) |
| JP (1) | JP5781093B2 (el) |
| KR (1) | KR101911324B1 (el) |
| CN (1) | CN103270024B (el) |
| AU (1) | AU2011345969B2 (el) |
| BR (1) | BR112013015604B1 (el) |
| CA (1) | CA2822787C (el) |
| CY (1) | CY1117560T1 (el) |
| DK (1) | DK2657227T3 (el) |
| EA (1) | EA022646B1 (el) |
| ES (1) | ES2571529T3 (el) |
| HK (1) | HK1185619A1 (el) |
| HR (1) | HRP20160465T1 (el) |
| HU (1) | HUE029976T2 (el) |
| MX (1) | MX2013007296A (el) |
| NZ (1) | NZ612336A (el) |
| PL (1) | PL2657227T3 (el) |
| PT (1) | PT2657227T (el) |
| TW (1) | TWI527799B (el) |
| WO (1) | WO2012086727A1 (el) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2021042126A (ja) * | 2017-12-27 | 2021-03-18 | 佐藤製薬株式会社 | アリールオキシ化合物 |
| WO2020129876A1 (ja) | 2018-12-17 | 2020-06-25 | 株式会社デ・ウエスタン・セラピテクス研究所 | イソキノリンスルホンアミドの新規な形態 |
| EP3900724A4 (en) * | 2018-12-18 | 2022-07-13 | D. Western Therapeutics Institute, Inc. | ISOQUINOLINE SULFONYL CHLORIDE ACID ADDITION SALT AND PROCESS FOR THE PREPARATION THEREOF |
| WO2020172615A1 (en) | 2019-02-22 | 2020-08-27 | Glaukos Corporation | Compounds for the treatment of ocular disease |
| EP3993878A4 (en) * | 2019-07-01 | 2023-11-08 | Curasen Therapeutics, Inc. | BETA-ADRENERGIC AGONIST AND METHOD OF USE THEREOF |
| CN110616439B (zh) * | 2019-10-31 | 2020-06-30 | 安阳师范学院 | 电化学氧化合成4-磺酸取代异喹啉酮衍生物的方法 |
| JP2023543140A (ja) * | 2020-08-31 | 2023-10-13 | ビューポイント セラピューティクス， インコーポレイテッド | 眼疾患を治療するための化合物および製剤 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6169085B1 (en) | 1995-03-10 | 2001-01-02 | G. D. Searle & Company | Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors |
| US5985870A (en) | 1995-03-10 | 1999-11-16 | G.D. Searle & Co. | Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors |
| US6667307B2 (en) | 1997-12-19 | 2003-12-23 | G.D. Searle & Co. | Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors |
| US5705500A (en) * | 1995-03-10 | 1998-01-06 | G.D. Searle & Co. | Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors |
| ATE289815T1 (de) | 1995-12-21 | 2005-03-15 | Alcon Lab Inc | Verwendung von substituierten isochinolinsulfonyl-verbindungen zur herstellung eines medikaments für die behandlung von glaukom und okularer ischämie |
| JP2005232175A (ja) * | 2004-01-21 | 2005-09-02 | Asahi Kasei Pharma Kk | ５−置換イソキノリン医薬 |
| US20050272723A1 (en) | 2004-04-27 | 2005-12-08 | The Regents Of The University Of Michigan | Methods and compositions for treating diseases and conditions associated with mitochondrial function |
| US20090275099A1 (en) | 2004-04-27 | 2009-11-05 | Regents Of The University Of Michigan | Methods and compositions for treating diseases and conditions associated with mitochondrial function |
| AU2005289881A1 (en) * | 2004-09-23 | 2006-04-06 | Amgen Inc. | Substituted sulfonamidopropionamides and methods of use |
| US7517991B2 (en) | 2004-10-12 | 2009-04-14 | Bristol-Myers Squibb Company | N-sulfonylpiperidine cannabinoid receptor 1 antagonists |
| US8455514B2 (en) * | 2008-01-17 | 2013-06-04 | Aerie Pharmaceuticals, Inc. | 6-and 7-amino isoquinoline compounds and methods for making and using the same |
| JP2011516482A (ja) | 2008-04-04 | 2011-05-26 | メルク・シャープ・エンド・ドーム・コーポレイション | β３アドレナリン作動性受容体アゴニストとしてのヒドロキシメチルピロリジン |
| ES2656903T3 (es) | 2008-07-08 | 2018-02-28 | Catabasis Pharmaceuticals, Inc. | Salicilatos acetilados de ácidos grasos y sus usos |
| ES2672624T3 (es) | 2009-05-01 | 2018-06-15 | Aerie Pharmaceuticals, Inc. | Inhibidores de mecanismo doble para el tratamiento de enfermedades |
| KR101732907B1 (ko) | 2009-06-19 | 2017-05-08 | 가부시키가이샤 디. 웨스턴 세라퓨틱스 겡큐쇼 | 치환된 이소퀴놀린 유도체 |
-
2011
- 2011-12-21 PT PT118511468T patent/PT2657227T/pt unknown
- 2011-12-21 AU AU2011345969A patent/AU2011345969B2/en active Active
- 2011-12-21 MX MX2013007296A patent/MX2013007296A/es active IP Right Grant
- 2011-12-21 DK DK11851146.8T patent/DK2657227T3/en active
- 2011-12-21 EA EA201390939A patent/EA022646B1/ru unknown
- 2011-12-21 BR BR112013015604-0A patent/BR112013015604B1/pt active IP Right Grant
- 2011-12-21 EP EP11851146.8A patent/EP2657227B1/en active Active
- 2011-12-21 ES ES11851146T patent/ES2571529T3/es active Active
- 2011-12-21 PL PL11851146.8T patent/PL2657227T3/pl unknown
- 2011-12-21 JP JP2012549860A patent/JP5781093B2/ja active Active
- 2011-12-21 US US13/995,300 patent/US8883792B2/en active Active
- 2011-12-21 NZ NZ612336A patent/NZ612336A/en unknown
- 2011-12-21 HU HUE11851146A patent/HUE029976T2/en unknown
- 2011-12-21 CN CN201180061578.2A patent/CN103270024B/zh active Active
- 2011-12-21 WO PCT/JP2011/079725 patent/WO2012086727A1/ja active Application Filing
- 2011-12-21 CA CA2822787A patent/CA2822787C/en active Active
- 2011-12-21 KR KR1020137015956A patent/KR101911324B1/ko active IP Right Grant
- 2011-12-22 TW TW100148109A patent/TWI527799B/zh active
-
2013
- 2013-11-26 HK HK13113181.7A patent/HK1185619A1/zh unknown
-
2016
- 2016-05-03 HR HRP20160465TT patent/HRP20160465T1/hr unknown
- 2016-05-27 CY CY20161100465T patent/CY1117560T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TWI527799B (zh) | 2016-04-01 |
| PL2657227T3 (pl) | 2016-09-30 |
| ES2571529T3 (es) | 2016-05-25 |
| US20130274269A1 (en) | 2013-10-17 |
| HRP20160465T1 (hr) | 2016-06-03 |
| EA201390939A1 (ru) | 2013-12-30 |
| EA022646B1 (ru) | 2016-02-29 |
| TW201305112A (zh) | 2013-02-01 |
| AU2011345969B2 (en) | 2016-04-21 |
| EP2657227B1 (en) | 2016-04-27 |
| HK1185619A1 (zh) | 2014-02-21 |
| EP2657227A4 (en) | 2013-11-27 |
| MX2013007296A (es) | 2013-08-26 |
| HUE029976T2 (en) | 2017-04-28 |
| BR112013015604A2 (pt) | 2018-07-24 |
| AU2011345969A1 (en) | 2013-07-11 |
| WO2012086727A1 (ja) | 2012-06-28 |
| CA2822787C (en) | 2018-07-17 |
| BR112013015604B1 (pt) | 2021-11-03 |
| CN103270024A (zh) | 2013-08-28 |
| PT2657227T (pt) | 2016-08-01 |
| JPWO2012086727A1 (ja) | 2014-06-05 |
| CN103270024B (zh) | 2015-07-08 |
| DK2657227T3 (en) | 2016-08-01 |
| CA2822787A1 (en) | 2012-06-28 |
| KR20130142163A (ko) | 2013-12-27 |
| KR101911324B1 (ko) | 2018-10-25 |
| NZ612336A (en) | 2014-05-30 |
| EP2657227A1 (en) | 2013-10-30 |
| JP5781093B2 (ja) | 2015-09-16 |
| US8883792B2 (en) | 2014-11-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1117560T1 (el) | Νεο υποκατασταθεν παραγωγο ισοκινολινης | |
| CY1119049T1 (el) | Υποκατεστημενα πυρρολιδινο-2-καρβοξαμιδια | |
| CY1120188T1 (el) | ΠΑΡΑΓΩΓΑ ΝΑΦΘΥΡΙΔΙΝΗΣ ΧΡΗΣΙΜΑ ΩΣ ΑΝΤΑΓΩΝΙΣΤΕΣ ΙΝΤΕΓΚΡΙΝΗΣ αvβ6 | |
| CY1118656T1 (el) | Παραγωγο πυριδονης | |
| CY1119220T1 (el) | Μονοκυκλικο παραγωγο πυριδινης | |
| CY1121626T1 (el) | Νεο παραγωγο υδροξαμικου οξεος ή αλας αυτου | |
| CY1120173T1 (el) | Ενωση πυραζολο-αμιδιου και φαρμακευτικες χρησεις αυτης | |
| CY1117752T1 (el) | Τετρακυκλικη ενωση | |
| CO7141456A2 (es) | Derivados de aril-sultamo como moduladores de rorc | |
| CY1115945T1 (el) | Παραγωγα πυραζολοκινολινονης, η παρασκευη τους και η θεραπευτικη τους χρηση | |
| CY1119423T1 (el) | Παραγωγο κυκλοαλκυλ-υποκατεστημενης ιμιδαζολης | |
| UA113643C2 (xx) | N-цикліламіди як нематоциди | |
| CY1120682T1 (el) | Ενωσεις για την προστασια κυτταρων | |
| ECSP13012362A (es) | Derivados de indolizina, su procedimiento de preparación | |
| CR11021A (es) | Derivados de quinolina como fungicidas | |
| BR112012029647A2 (pt) | novos derivados de pirimidinas | |
| ECSP10010334A (es) | Derivados de quinolina y su uso como fungicidas | |
| CY1118883T1 (el) | Μεθοδος παρασκευης βορτιοξετινης | |
| ECSP11011206A (es) | Nuevos herbicidas. | |
| CY1117688T1 (el) | Ενωσεις τετραϋδροπυρρολοθειαζινης | |
| ECSP11011218A (es) | Herbicidas derivados de ciclopentanodiona. | |
| RU2012148909A (ru) | Новый синтез соединений тиазолидиндиона | |
| UA106880C2 (uk) | Нові гербіциди | |
| UY34251A (es) | derivados de isoxazolina como compuestos insecticidas. | |
| MX2017016030A (es) | Derivado de dihidropirrolopirazol sustituido. |